Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines against Campylobacter jejuni

D A Scott1

  • 1Enteric Diseases Program, Naval Medical Research Institute, Bethesda, Maryland 20852, USA.

The Journal of Infectious Diseases
|December 13, 1997
PubMed
Summary

Campylobacter jejuni causes widespread diarrhea and serious health issues. Research is exploring an oral killed whole-cell vaccine, showing promise in animal models and early human trials for prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Filifactor alocis</i> Pathogenicity Requires TLR2 and the Oral Microbiome.

Journal of dental research·2025
Same author

Can lessons be learned from reviewing peri-operative cardiac arrests?

Anaesthesia·2023
Same author

The long-term incidence of chronic post-surgical pain after coronary artery bypass surgery - A prospective observational study.

European journal of pain (London, England)·2023
Same author

Acute peri-operative neurocognitive disorders: a narrative review.

Anaesthesia·2022
Same author

Quantitative evaluation of aerosol generation during manual facemask ventilation.

Anaesthesia·2021
Same author

Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction.

Journal of dental research·2021

Area of Science:

  • Microbiology
  • Vaccinology
  • Infectious Diseases

Background:

  • Campylobacter jejuni is a leading global cause of bacterial diarrhea.
  • Infections can lead to severe gastrointestinal illness and postinfectious complications like reactive arthritis and Guillain-Barré syndrome.
  • Developing a vaccine is crucial for preventing disease and reducing colonization.

Purpose of the Study:

  • To review the potential for developing a Campylobacter jejuni vaccine.
  • To identify challenges and progress in vaccine development efforts.

Main Methods:

  • Review of epidemiological and volunteer studies on Campylobacter jejuni.
  • Analysis of challenges in developing live attenuated and subunit vaccines.
  • Evaluation of data from animal models and early-phase human trials for an oral killed whole-cell vaccine.

Main Results:

  • Live attenuated and subunit vaccine approaches face hurdles due to limited understanding of pathogenesis and lack of conserved antigens.
  • An oral killed, whole-cell Campylobacter jejuni vaccine demonstrated safety and efficacy in animal models.
  • This vaccine candidate is currently undergoing Phase I human volunteer studies.

Conclusions:

  • Preventing Campylobacter jejuni infections through vaccination is feasible.
  • An oral killed, whole-cell vaccine represents a promising strategy, with ongoing human trials to assess its safety and immunogenicity.

Related Experiment Videos